Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells-identification of a novel androgen response element

Marilena Lanzino, Diego Sisci, Catia Morelli, Cecilia Garofalo, Stefania Catalano, Ivan Casaburi, Claudia Capparelli, Cinzia Giordano, Francesca Giordano, Marcello Maggiolini, Sebastiano Andò

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Cyclin D1 gene (CCND1) is a critical mitogen-regulated cell-cycle control element whose transcriptional modulation plays a crucial role in breast cancer growth and progression. Here we demonstrate that the non-aromatizable androgen 5-α-dihydrotestosterone (DHT) inhibits endogenous cyclin D1 expression, as evidenced by reduction of cyclin D1 mRNA and protein levels, and decrease of CCND1-promoter activity, in MCF-7 cells. The DHT-dependent inhibition of CCND1 gene activity requires the involvement and the integrity of the androgen receptor (AR) DNA-binding domain. Site directed mutagenesis, DNA affinity precipitation assay, electrophoretic mobility shift assay and chromatin immunoprecipitation analyses indicate that this inhibitory effect is ligand dependent and it is mediated by direct binding of AR to an androgen response element (CCND1-ARE) located at -570 to -556-bp upstream of the transcription start site, in the cyclin D1 proximal promoter. Moreover, AR-mediated repression of the CCND1 involves the recruitment of the atypical orphan nuclear receptor DAX1 as a component of a multiprotein repressor complex also embracing the participation of Histone Deacetylase 1. In conclusion, identification of the CCND1-ARE allows defining cyclin D1 as a specific androgen target gene in breast and might contribute to explain the molecular basis of the inhibitory role of androgens on breast cancer cells proliferation.

Original languageEnglish
Article numbergkq278
Pages (from-to)5351-5365
Number of pages15
JournalNucleic Acids Research
Volume38
Issue number16
DOIs
Publication statusPublished - Apr 26 2010

Fingerprint

bcl-1 Genes
Cyclin D1
Androgen Receptors
Response Elements
Androgens
Breast Neoplasms
Dihydrotestosterone
Histone Deacetylase 1
Orphan Nuclear Receptors
Multiprotein Complexes
Chromatin Immunoprecipitation
Transcription Initiation Site
DNA
MCF-7 Cells
Electrophoretic Mobility Shift Assay
Site-Directed Mutagenesis
Cell Cycle Checkpoints
Mitogens
Genes
Breast

ASJC Scopus subject areas

  • Genetics
  • Medicine(all)

Cite this

Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells-identification of a novel androgen response element. / Lanzino, Marilena; Sisci, Diego; Morelli, Catia; Garofalo, Cecilia; Catalano, Stefania; Casaburi, Ivan; Capparelli, Claudia; Giordano, Cinzia; Giordano, Francesca; Maggiolini, Marcello; Andò, Sebastiano.

In: Nucleic Acids Research, Vol. 38, No. 16, gkq278, 26.04.2010, p. 5351-5365.

Research output: Contribution to journalArticle

Lanzino, M, Sisci, D, Morelli, C, Garofalo, C, Catalano, S, Casaburi, I, Capparelli, C, Giordano, C, Giordano, F, Maggiolini, M & Andò, S 2010, 'Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells-identification of a novel androgen response element', Nucleic Acids Research, vol. 38, no. 16, gkq278, pp. 5351-5365. https://doi.org/10.1093/nar/gkq278
Lanzino, Marilena ; Sisci, Diego ; Morelli, Catia ; Garofalo, Cecilia ; Catalano, Stefania ; Casaburi, Ivan ; Capparelli, Claudia ; Giordano, Cinzia ; Giordano, Francesca ; Maggiolini, Marcello ; Andò, Sebastiano. / Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells-identification of a novel androgen response element. In: Nucleic Acids Research. 2010 ; Vol. 38, No. 16. pp. 5351-5365.
@article{7f061fceefb844a98425c7596b423e36,
title = "Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells-identification of a novel androgen response element",
abstract = "Cyclin D1 gene (CCND1) is a critical mitogen-regulated cell-cycle control element whose transcriptional modulation plays a crucial role in breast cancer growth and progression. Here we demonstrate that the non-aromatizable androgen 5-α-dihydrotestosterone (DHT) inhibits endogenous cyclin D1 expression, as evidenced by reduction of cyclin D1 mRNA and protein levels, and decrease of CCND1-promoter activity, in MCF-7 cells. The DHT-dependent inhibition of CCND1 gene activity requires the involvement and the integrity of the androgen receptor (AR) DNA-binding domain. Site directed mutagenesis, DNA affinity precipitation assay, electrophoretic mobility shift assay and chromatin immunoprecipitation analyses indicate that this inhibitory effect is ligand dependent and it is mediated by direct binding of AR to an androgen response element (CCND1-ARE) located at -570 to -556-bp upstream of the transcription start site, in the cyclin D1 proximal promoter. Moreover, AR-mediated repression of the CCND1 involves the recruitment of the atypical orphan nuclear receptor DAX1 as a component of a multiprotein repressor complex also embracing the participation of Histone Deacetylase 1. In conclusion, identification of the CCND1-ARE allows defining cyclin D1 as a specific androgen target gene in breast and might contribute to explain the molecular basis of the inhibitory role of androgens on breast cancer cells proliferation.",
author = "Marilena Lanzino and Diego Sisci and Catia Morelli and Cecilia Garofalo and Stefania Catalano and Ivan Casaburi and Claudia Capparelli and Cinzia Giordano and Francesca Giordano and Marcello Maggiolini and Sebastiano And{\`o}",
year = "2010",
month = "4",
day = "26",
doi = "10.1093/nar/gkq278",
language = "English",
volume = "38",
pages = "5351--5365",
journal = "Nucleic Acids Research",
issn = "0305-1048",
publisher = ". This work is written by (a) US Government employee(s) and is in the public domain in the US",
number = "16",

}

TY - JOUR

T1 - Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells-identification of a novel androgen response element

AU - Lanzino, Marilena

AU - Sisci, Diego

AU - Morelli, Catia

AU - Garofalo, Cecilia

AU - Catalano, Stefania

AU - Casaburi, Ivan

AU - Capparelli, Claudia

AU - Giordano, Cinzia

AU - Giordano, Francesca

AU - Maggiolini, Marcello

AU - Andò, Sebastiano

PY - 2010/4/26

Y1 - 2010/4/26

N2 - Cyclin D1 gene (CCND1) is a critical mitogen-regulated cell-cycle control element whose transcriptional modulation plays a crucial role in breast cancer growth and progression. Here we demonstrate that the non-aromatizable androgen 5-α-dihydrotestosterone (DHT) inhibits endogenous cyclin D1 expression, as evidenced by reduction of cyclin D1 mRNA and protein levels, and decrease of CCND1-promoter activity, in MCF-7 cells. The DHT-dependent inhibition of CCND1 gene activity requires the involvement and the integrity of the androgen receptor (AR) DNA-binding domain. Site directed mutagenesis, DNA affinity precipitation assay, electrophoretic mobility shift assay and chromatin immunoprecipitation analyses indicate that this inhibitory effect is ligand dependent and it is mediated by direct binding of AR to an androgen response element (CCND1-ARE) located at -570 to -556-bp upstream of the transcription start site, in the cyclin D1 proximal promoter. Moreover, AR-mediated repression of the CCND1 involves the recruitment of the atypical orphan nuclear receptor DAX1 as a component of a multiprotein repressor complex also embracing the participation of Histone Deacetylase 1. In conclusion, identification of the CCND1-ARE allows defining cyclin D1 as a specific androgen target gene in breast and might contribute to explain the molecular basis of the inhibitory role of androgens on breast cancer cells proliferation.

AB - Cyclin D1 gene (CCND1) is a critical mitogen-regulated cell-cycle control element whose transcriptional modulation plays a crucial role in breast cancer growth and progression. Here we demonstrate that the non-aromatizable androgen 5-α-dihydrotestosterone (DHT) inhibits endogenous cyclin D1 expression, as evidenced by reduction of cyclin D1 mRNA and protein levels, and decrease of CCND1-promoter activity, in MCF-7 cells. The DHT-dependent inhibition of CCND1 gene activity requires the involvement and the integrity of the androgen receptor (AR) DNA-binding domain. Site directed mutagenesis, DNA affinity precipitation assay, electrophoretic mobility shift assay and chromatin immunoprecipitation analyses indicate that this inhibitory effect is ligand dependent and it is mediated by direct binding of AR to an androgen response element (CCND1-ARE) located at -570 to -556-bp upstream of the transcription start site, in the cyclin D1 proximal promoter. Moreover, AR-mediated repression of the CCND1 involves the recruitment of the atypical orphan nuclear receptor DAX1 as a component of a multiprotein repressor complex also embracing the participation of Histone Deacetylase 1. In conclusion, identification of the CCND1-ARE allows defining cyclin D1 as a specific androgen target gene in breast and might contribute to explain the molecular basis of the inhibitory role of androgens on breast cancer cells proliferation.

UR - http://www.scopus.com/inward/record.url?scp=77956504679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956504679&partnerID=8YFLogxK

U2 - 10.1093/nar/gkq278

DO - 10.1093/nar/gkq278

M3 - Article

VL - 38

SP - 5351

EP - 5365

JO - Nucleic Acids Research

JF - Nucleic Acids Research

SN - 0305-1048

IS - 16

M1 - gkq278

ER -